Business is Good, Upside is Not
Catamaran (CTRX) has a strong pipeline of new business, and is keeping 98% of its current customers, but upside isn’t great, so I’m selling CTRX.
Catamaran (CTRX) has a strong pipeline of new business, and is keeping 98% of its current customers, but upside isn’t great, so I’m selling CTRX.
As I said last qtr, Catamaran (CTRX) is fairly valued here, but CTRX is a good stock for the long-term,
Catamaran’s (CTRX) 2014 earnings are getting hurt from higher expenses and a higher tax rate.
Catamaran’s (CTRX) management just slashed 2014 estimates. The stock’s lucky I’m even sticking with it.
Shares of Catamaran (CTRX) are on a dip, and provide excellent upside of more than 50% to the stock’s Fair Value.
Shares of Catamaran (CTRX) are now basing after a strong run-up last year. Now tension is building and CTRX could be ready to make a move in 2014.
Catamaran (CTRX) just signed a new deal with Cigna, and I will replace Francesca’s (FRAN) with CTRX in the Aggressive Growth Portfolio.
What’s on the mind of investors in regards to Catamaran (CTRX)? It’s all about the Cigna business, which was a third of 2012 sales.
Quarterly estimates for Catamaran (CTRX) look great. I’m expected good growth from CTRX the next two years.
Take a break Catamaran (CTRX), you deserve a break after the 75% rise your stock’s had this year. Looking at estimates, it seems like another rise is on the horizon.
We need to look to the future with Catamaran (CTRX). CTRX is overvalued now, but profit growth is set to jump 65% next year.
SXCI Health Solutions (SXCI) and Catalyst Health Solutions (CHSI) are now merged into one stock Catamaran (CTRX). Here’s a look at CTRX’s on day one.